Patents by Inventor Mansel Griffiths

Mansel Griffiths has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11857581
    Abstract: Molecules secreted or derived from probiotic bacteria are provided for use in compositions and methods for the treatment and/or prevention of infection by pathogenic viruses. The isolated secreted molecules can also be used in nutritional or medical food products which provide probiotics to the gastrointestinal tract of a mammal.
    Type: Grant
    Filed: June 12, 2020
    Date of Patent: January 2, 2024
    Assignee: MicroSintesis Inc.
    Inventor: Mansel Griffiths
  • Publication number: 20230226139
    Abstract: This invention provides isolated and characterized secreted molecules from probiotic bacteria for use in compositions and methods for the treatment and/or prevention of infection by harmful pathogenic bacteria. The isolated secreted molecules can also be used in nutritional or medical food products which provide probiotics to the gastrointestinal tract of a mammal.
    Type: Application
    Filed: February 13, 2023
    Publication date: July 20, 2023
    Inventors: Mansel Griffiths, Maira Medellin-Pena, Veronique Delcenserie
  • Publication number: 20210128650
    Abstract: Molecules secreted or derived from probiotic bacteria are provided for use in compositions and methods for the treatment and/or prevention of infection by pathogenic viruses. The isolated secreted molecules can also be used in nutritional or medical food products which provide probiotics to the gastrointestinal tract of a mammal.
    Type: Application
    Filed: June 12, 2020
    Publication date: May 6, 2021
    Inventor: Mansel Griffiths
  • Patent number: 10716817
    Abstract: Molecules secreted or derived from probiotic bacteria are provided for use in compositions and methods for the treatment and/or prevention of infection by pathogenic viruses. The isolated secreted molecules can also be used in nutritional or medical food products which provide probiotics to the gastrointestinal tract of a mammal.
    Type: Grant
    Filed: December 8, 2017
    Date of Patent: July 21, 2020
    Assignee: UNIVERSITY OF GUELPH
    Inventor: Mansel Griffiths
  • Patent number: 10687543
    Abstract: This invention provides isolated and characterized secreted molecules from probiotic bacteria for use in compositions and methods for the treatment and/or prevention of infection by harmful pathogenic bacteria. The isolated secreted molecules can also be used in nutritional or medical food products which provide probiotics to the gastrointestinal tract of a mammal.
    Type: Grant
    Filed: September 6, 2017
    Date of Patent: June 23, 2020
    Assignee: University of Guelph
    Inventors: Mansel Griffiths, Maira Medellin-Pena, Veronique Delcenserie
  • Publication number: 20200178567
    Abstract: This invention provides isolated and characterized secreted molecules from probiotic bacteria for use in compositions and methods for the treatment and/or prevention of infection by harmful pathogenic bacteria. The isolated secreted molecules can also be used in nutritional or medical food products which provide probiotics to the gastrointestinal tract of a mammal.
    Type: Application
    Filed: February 25, 2020
    Publication date: June 11, 2020
    Inventors: Mansel Griffiths, Maira Medellin-Pena, Veronique Delcenserie
  • Publication number: 20180177834
    Abstract: Molecules secreted or derived from probiotic bacteria are provided for use in compositions and methods for the treatment and/or prevention of infection by pathogenic viruses. The isolated secreted molecules can also be used in nutritional or medical food products which provide probiotics to the gastrointestinal tract of a mammal.
    Type: Application
    Filed: December 8, 2017
    Publication date: June 28, 2018
    Inventor: Mansel Griffiths
  • Patent number: 9861666
    Abstract: Molecules secreted or derived from probiotic bacteria are provided for use in compositions and methods for the treatment and/or prevention of infection by pathogenic viruses. The isolated secreted molecules can also be used in nutritional or medical food products which provide probiotics to the gastrointestinal tract of a mammal.
    Type: Grant
    Filed: August 12, 2014
    Date of Patent: January 9, 2018
    Inventor: Mansel Griffiths
  • Publication number: 20180000126
    Abstract: This invention provides isolated and characterized secreted molecules from probiotic bacteria for use in compositions and methods for the treatment and/or prevention of infection by harmful pathogenic bacteria. The isolated secreted molecules can also be used in nutritional or medical food products which provide probiotics to the gastrointestinal tract of a mammal.
    Type: Application
    Filed: September 6, 2017
    Publication date: January 4, 2018
    Inventors: Mansel Griffiths, Maira Medellin-Pena, Veronique Delcenserie
  • Publication number: 20160024478
    Abstract: An active phage bio-ink composition and phage-based bioactive paper, wherein the phage is oriented and immobilized at the paper surface through heads, with the phage tail fibers free to capture target bacterial pathogens.
    Type: Application
    Filed: July 24, 2015
    Publication date: January 28, 2016
    Inventors: Mansel Griffiths, Hany Anany, Lioubov Brovko
  • Publication number: 20150044188
    Abstract: Molecules secreted or derived from probiotic bacteria are provided for use in compositions and methods for the treatment and/or prevention of infection by pathogenic viruses. The isolated secreted molecules can also be used in nutritional or medical food products which provide probiotics to the gastrointestinal tract of a mammal.
    Type: Application
    Filed: August 12, 2014
    Publication date: February 12, 2015
    Inventor: Mansel Griffiths
  • Publication number: 20110262400
    Abstract: This invention provides isolated and characterized secreted molecules from probiotic bacteria for use in compositions and methods for the treatment and/or prevention of infection by harmful pathogenic bacteria. The isolated secreted molecules can also be used in nutritional or medical food products which provide probiotics to the gastrointestinal tract of a mammal.
    Type: Application
    Filed: June 26, 2009
    Publication date: October 27, 2011
    Applicant: UNIVERSITY OF GUELPH
    Inventors: Mansel Griffiths, Maira Medellin-Pena, Veronique Delcenserie
  • Patent number: 6696264
    Abstract: The present invention relates to bioassay materials useful for the detection of toxic substances and, more particularly, to packaging materials for food and other products, along with methods for their manufacture and use. The invention provides a unique composite material capable of detecting and identifying multiple biological materials within a single package. The biological material identification system is designed for incorporation into existing types of flexible packaging material such as polyvinylchloride or polyolefin films, and its introduction into the existing packaging infrastructure will require little or no change to present systems or procedures.
    Type: Grant
    Filed: April 17, 2001
    Date of Patent: February 24, 2004
    Assignee: Toxin Alert, Inc.
    Inventors: William T. Bodenhamer, George Jackowski, Eric Davies, Mansel Griffiths
  • Publication number: 20020009811
    Abstract: The present invention relates to bioassay materials useful for the detection of toxic substances and, more particularly, to packaging materials for food and other products, along with methods for their manufacture and use. The invention provides a unique composite material capable of detecting and identifying multiple biological materials within a single package. The biological material identification system is designed for incorporation into existing types of flexible packaging material such as polyvinylchloride or polyolefin films, and its introduction into the existing packaging infrastructure will require little or no change to present systems or procedures.
    Type: Application
    Filed: April 17, 2001
    Publication date: January 24, 2002
    Inventors: William T. Bodenhamer, George Jackowski, Eric Davies, Mansel Griffiths